Perhaps, in the next three years, we will see the following happen to the new Biota company:
+ Lani ROW is progressing as planned and the US government pre-solicitation orders placed for Lani.
+ Vapendavir is licensed to a third party for a big upfront payment plus >10% royalties
+ Gyrase program gets the US government funding for further developement
+ HEP C programs are advanced into clinical stage.
Just my wishes. LOL.....
- Forums
- ASX - By Stock
- BTA
- proposed new ceo is
proposed new ceo is, page-34
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)